title: California Stem Cell Research and Cures Act: what to expect from stem cell research?
abstract: On November 2, 2004 California voters approved Proposition 71, the California Stem Cell Research and Cures Act ("Act"), a $3 billion bond measure to advance stem cell research over the next ten years. The Act also created the California Institute for Regenerative Medicine (CIRM) and the Independent Citizens Oversight Committee (ICOC) which will govern the Institute, and make grants and loans for stem cell research and research facilities. This article will cover the history of the "Act", its potential impact on NIH's current stem cell program, and what are other states doing to compete with California's revolutionary efforts. In addition, the article will discuss the criteria for California's grant applicants under the Act and the legal issues surrounding the new discoveries funded by the Act.
authors.affiliation: BIOCOM, California, USA.
authors.forename: Joe
authors.initials: J
authors.lastname: Panetta
authors.forename: John
authors.initials: J
authors.lastname: Wetherell
authors.forename: Michelle
authors.initials: M
authors.lastname: Mehok
mesh_terms: D002140:California; D019976:Cloning, Organism; D033041:Embryo Research / Q000191:economics* / Q000331:legislation & jurisprudence*; D004622:Embryo, Mammalian / Q000166:cytology*; D035082:Federal Government; D005380:Financing, Government; D006801:Humans; D007883:Legislation, Medical; D009316:National Institutes of Health (U.S.); D010330:Patents as Topic; D017149:Private Sector; D011640:Public Policy; D012109:Research Support as Topic; D013219:State Government; D013234:Stem Cells / Q000166:cytology; D014481:United States